Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Minority Interest (2023 - 2025)

Historic Minority Interest for Guardian Pharmacy Services (GRDN) over the last 3 years, with Q3 2025 value amounting to $11.7 million.

  • Guardian Pharmacy Services' Minority Interest rose 8551.11% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year increase of 8551.11%. This contributed to the annual value of $7.3 million for FY2024, which is 7691.94% down from last year.
  • According to the latest figures from Q3 2025, Guardian Pharmacy Services' Minority Interest is $11.7 million, which was up 8551.11% from $10.1 million recorded in Q2 2025.
  • In the past 5 years, Guardian Pharmacy Services' Minority Interest ranged from a high of $31.6 million in Q4 2023 and a low of $6.3 million during Q3 2024
  • Moreover, its 3-year median value for Minority Interest was $8.7 million (2024), whereas its average is $12.4 million.
  • In the last 5 years, Guardian Pharmacy Services' Minority Interest tumbled by 7691.94% in 2024 and then skyrocketed by 8551.11% in 2025.
  • Over the past 3 years, Guardian Pharmacy Services' Minority Interest (Quarter) stood at $31.6 million in 2023, then crashed by 76.92% to $7.3 million in 2024, then skyrocketed by 60.73% to $11.7 million in 2025.
  • Its Minority Interest was $11.7 million in Q3 2025, compared to $10.1 million in Q2 2025 and $7.1 million in Q1 2025.